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a  b  s  t  r  a  c  t
Cognitive impairment is deﬁned as a newly appeared deﬁcit in at least two areas of cogni-
tive  functions, including disturbances in memory, executive functioning, attention or speed
of  information processing, perceptual motor abilities, or language. Cognitive impairment is
highly prevalent in ESRD patients when compared with the general population. It has also
been  associated with a decreased quality of life. Cognitive functions in patients with ESRD
showed improvement with dialysis and renal transplantation. These ﬁndings illustrate the
potential importance of evaluating and comparing the effects of hemodialysis and trans-
plantation regarding cognitive performance and thus quality of life in ESRD patients and
normal subjects. This study was carried out in 100 patients (50 ESRD patients on regular
hemodialysis for at least 6 months and 50 post-transplant patients who had maintained
successful kidney graft for at least 3 months). All patients underwent laboratory and psy-
chometric scoring tests, including trail making test part A, trail making test part B, digit span,
and  mini-mental state examination. Thirty healthy adults matched by age and sex served
as  a control group. The results showed signiﬁcant differences in cognitive function tests
results between transplant and hemodialysis patients (P < 0.01), suggesting that transplant
patients were superior in their cognitive performance, with the correction of anemia being
the  most important factor for improving cognitive performance in both groups. There were
no  signiﬁcant differences between transplant patients and control subjects in psychometric
measures (P > 0.05).
Conclusion: Renal transplantation as a modality of treatment, in ESRD patients, is superior
to  hemodialysis in terms of cognitive performance improvement.©  2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author.
E-mail addresses: haitham ezzat@hotmail.com, drhaitham77@gmail.com (H. Ezzat).
ttp://dx.doi.org/10.1016/j.nefro.2015.07.004
211-6995/© 2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Estudio  comparativo  de  la  inﬂuencia  de  la  hemodiálisis  y  el  trasplante
renal  en  la  función  cognitiva  de  los  pacientes  con  enfermedad  renal
terminal
Palabras clave:
Hemodiálisis
Trasplante
Función cognitiva
r  e  s  u  m  e  n
El deterioro cognitivo se deﬁne como un déﬁcit de nueva aparición en al menos dos áreas de
las  funciones cognitivas, incluidas las alteraciones de la memoria, la función ejecutiva, la
atención o la rapidez de procesamiento de la información, las capacidades motoras percep-
tivas o el lenguaje. El deterioro cognitivo tiene una prevalencia elevada en los pacientes con
ERT  en comparación con la población general. También se ha asociado a una reducción de
la  calidad de vida. Las funciones cognitivas de los pacientes con ERT mostraron una mejoría
con la diálisis y con el trasplante renal. Estas observaciones ilustran la posible importancia
de  la evaluación y comparación de los efectos de la hemodiálisis y el trasplante sobre la fun-
ción  cognitiva y, por tanto, sobre la calidad de vida, en relación con los pacientes con ERT y
los  individuos normales. El estudio se llevó a cabo en un total de 100 pacientes (50 pacientes
con  ERT en hemodiálisis regular durante un mínimo de 6 meses y 50 pacientes trasplanta-
dos que habían mantenido un buen funcionamiento del injerto renal durante un mínimo
de  3 meses). En todos los casos se realizaron análisis de laboratorio y tests psicométricos
como el test del trazo (trail making test) parte A, el test del trazo parte B, el test de memoria
inmediata de números (digit span) y la mini mental state examination, y se compararon con
los  de 30 adultos sanos igualados en cuanto a edad y sexo, que se utilizaron como grupo de
control. Los resultados pusieron de maniﬁesto diferencias signiﬁcativas en los tests de fun-
ción cognitiva entre los pacientes trasplantados y los hemodializados (p < 0,01), y sugirieron
que  los pacientes trasplantados obtenían mejores resultados de función cognitiva y que la
corrección de la anemia era el factor más importante en esa mejora en ambos grupos. No
hubo diferencias signiﬁcativas entre los pacientes trasplantados y los individuos de control
por  lo que respecta a los parámetros psicométricos (p > 0,05).
Conclusión: El trasplante renal como modalidad de tratamiento, en los pacientes con ERT, es
superior a la hemodiálisis por lo que respecta a la mejora de la función cognitiva.
©  2015 Sociedad Espan˜ola de Nefrología. Publicado por Elsevier España, S.L.U. Este es un
artículo Open Access bajo la licencia CC BY-NC-NDIntroduction
Cognitive impairment is deﬁned as a new deﬁcit in at least
two areas of cognitive functioning. These may include dis-
turbances in memory  (learning or recalling new information),
executive functioning (e.g., planning, reasoning), attention or
speed of information processing (e.g., concentration, rapidity
of assimilating or analyzing information), perceptual motor
abilities (e.g., integrating visual, tactile, or auditory informa-
tion with motor activities), or language (e.g., word-ﬁnding
difﬁculties, reduced ﬂuency).1 Cognitive impairment is a
well-recognized manifestation of uremia.2 The severity of
kidney disease is associated with the severity of cognitive
impairment, independent of age, education and other key
confounders.3 In hemodialysis patients, the prevalence of
cognitive impairment has been estimated at 30–60% at least
twice the values observed in age-matched controls.4 Diagnosis
of cognitive impairment is important as cognitive impair-
ment and dementia are associated with an increased risk
1of death in dialysis patients. Recent data in this regard
suggest that individuals at all stages of CKD may have a
higher risk of developing dementia and cognitive impairment
than those without CKD.4 Cognitive function in patients with(http://creativecommons.org/licenses/by-nc-nd/4.0/).
ESRD has improved with renal transplantation.2 Studies on
outcomes after transplantation have traditionally measured
post-operative survival and complication rates. One area that
has received less attention is the impact of dialysis and trans-
plantation on neuropsychological functioning.5
Materials  and  methods
This cross-sectional design study was conducted on (100)
Egyptian patients as well as (30) healthy subjects (control
group) matched as regards age, sex and education. The
patients were classiﬁed into two groups. Group I: Included
(50) ESRD patients on regular hemodialysis, thrice weekly,
4 h for each session. All patients were on regular HD for at
least 6 months. This interval was to ensure enough time for
maintenance HD to correct and avoid uremic complications.
Group II: Included (50) post renal transplantation patients
who had maintained successful kidney graft for at least 3
months duration. This interval was to ensure some distance
from potential early post-operative complications and to allow
some time for adjustment of the transplant and immuno-
suppressive regimen. We  excluded from the study patients
with evident cerebrovascular disease, thyroid disease, severe
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Table 1 – Mini-mental state examination.
Item Maximum score
Orientation
What is the (year) (season) (date) (month)? 5
Where are we (state) (country) (town)
(hospital) (ﬂoor)?
5
Registration
Name three objects: 1 s to say each. Ask
the patients for all three. Give 1 point
for each correct answer. Repeat them
until all three can be repeated
3
Attention and calculation
Serial subtraction of 7.1 point for each
correct. Stop after ﬁve answers.
Alternatively: Spell “world” backwards
5
Recall
Ask for the three objects repeated above.
1 point for each correct
3
Language
Name a pencil and a watch 2
Repeat the following: “No ifs, ands or
buts”
1
Follow a three-stage command: “Take a
paper in your right hand, fold it in half
and put into the ﬂoor”
3
Read and obey the following: “Close your
eyes”
1
Write a sentence 1Fig. 1 – TMT-B.
nemia, uncontrolled hypertension, malnutrition, major psy-
hiatric illness, major visual or hearing impairment, unstable
oronary heart disease, collagen vascular disease and vasculi-
is. All the medications were revised to exclude any drugs that
ight have an effect on the cognitive function except steroids
nd cyclosporine in all transplantation patients group. We
btained history, clinical examination and laboratory inves-
igations from all the patients. Psychometric tests were done
n the dialysis off day, which included trail making test part
 (TMT-A) that requires participants to connect 25 randomly
rranged numbers in the proper order, trail making test part B
TMT-B), which requires that the subject connects with lines
n a given sequence circled digits and letters randomly dis-
ributed on a page as shown in Fig. 1. The prescribed sequence
s from 1 to A to 2 to B to 3 to C, etc., and performance is scored
n terms of time to complete the task correctly. The TMT-B
ssesses attention, visual scanning, psychomotor speed and
bility to sequence to shift the cognitive set.6 The digit span
D-span) psychometric test is a widely used auditory verbal
hort-term (working) memory  test. It requires the subject to
epeat a spoken string of digits, two trials each, for stings three
o nine digits in the forward order and two to eight digits in
he reverse order.7 The psychometric mini-mental state exam-
nation as shown in Table 1 is a widely used well validated
creening tool for cognitive impairment. It tests ﬁve areas of
ognitive function; the ﬁrst area includes orientation, which is
ssessed by asking the usual questions about time, day, date
nd location; the second area includes registration, which is
ctually a short term memory  test where the subject must
ecall three objects named by the examiner; the third and
ourth area include attention and calculation, which are mea-
ured by having the subject begin with the number 100 and
ount backwards by seven (serial 7s); then, recall by which
he subject must recall the three objects named previously.
inally, language functions are assessed by having the subject
ame simple objects, repeat a sentence and follow a three-
tage command. A constructional task is also included in the
anguage section where the subject must copy overlappingCopy a design of two intersecting
pentagons
1
pentagons. Each discrete subtask completed correctly earns
one point toward a maximum score of 30. The mild cogni-
tive impairment score ranges between 26 and 28, moderate
cognitive impairment score between 18 and 25 and severe
impairment below 18.12.8
Statistical  analysis
The statistical analysis of data was performed by using excel
program and the statistical package for social science (SPSS)
program version 10. The description of the data done was writ-
ten in the form of the mean (±) SD for quantitative data. The
analysis of the data was done to test statistically signiﬁcant
difference between groups, where P-value less than 0.05 was
considered as signiﬁcant. For quantitative data, Student’s t-
test was used to compare the two groups and paired sample
t-test was used to compare one group at different measure-
ments. One way analysis of variance (ANOVA) test with post
hoc analysis was used to compare more  than two groups. To
test the association between variables, Pearson correlation co-
efﬁciency test was used.
Results
This study included 100 patients in addition to 30 healthy con-
trols, 60% males and 40% females with a median age of 45
years and a range from 22 to 60 years, and the mean of the
education period was 8.14 ± 3.5 years. There were no signif-
icant differences in the gender, median age and education
years among the different study groups or controls. Table 2
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Table 2 – Results of the subjects.
Variables Group I
N = 50
Group II
N = 50
t  P
Serum albumin 3.2 ± 0.9 3.5 ± 1 0.9 >0.05
Hemoglobin 10.1 ± 3.2 10.9 ± 2.6 1.1 <0.05
Calcium 7.9 ± 1.5 8 ± 1.2 0.3 >0.05
Phosphorus 4 ± 1.2 4.3 ± 1.5 0.6 >0.05
Table 3 – Comparison between group I versus group II as
regard psychometric tests.
Variables Group I
N = 50
Group II
N = 50
t  P
D-span 3.9 ± 1.5 7.5 ± 1.5 7.7 <0.01
TMT-A 97 ± 41 33.7 ± 8 10 <0.01
TMT-B 194 ± 72 110 ± 28.6 7.6 <0.01
MMSE 28.4 ± 7 30  ± 1.3 1.1 >0.05
Bold: these values are signiﬁcant values to differentiate them from
non signiﬁcant values.
Table 4 – Comparison between group I versus controls
group as regard psychometric tests.
Variables Group I
N = 50
Controls
N = 30
t  P
D-span 3.9 ± 1.5 7.9 ± 3.1 7  <0.01
TMT-A 97 ± 41 34.7 ± 9 8 <0.01
TMT-B 194 ± 72 107 ± 26 6 <0.01
MMSE 28.4 ± 7 30 ± 0.00 1.1 >0.05
Table 5 – Comparison between group II versus controls
group as regard psychometric tests.
Variables Group II
N = 50
Controls
N  = 30
t  P
D-span 7.5 ± 1.5 7.9 ± 3.1 0.4 >0.05
TMT-A 33.7 ± 8 34.7 ± 9 0.6 >0.05
MMSETMT-BTMT-AD-span
0
50
100
150
200
250
ControlsGraftHD
Fig. 2 – Comparative presentation of all cognitive function
tests in three groups.
Table 6 – Correlation between psychometric tests versus
each other and versus other variables among group I.
Variables Age Duration Hemoglobin URR
r P r P r P r P
D-span −0.02 >0.05 −0.04 >0.05 0.3 <0.05 0.17 >0.05
TMT-A 0.07 >0.05 0.10 >0.05 0.32 <0.05 0.2 >0.05
TMT-B 0.15 >0.05 −0.09 >0.05 0.39 <0.05 0.08 >0.05
MMSE 0.09 >0.05 0.14 >0.05 0.45 <0.05 0.25 >0.05
Table 7 – Correlation between psychometric tests versus
each other and versus other variables among group II.
Variables Age Duration Hemoglobin
r P r P r P
D-span −0.12 >0.05NS −0.14 >0.05NS 0.4 <0.05S
TMT-A 0.06 >0.05NS 0.16 >0.05NS 0.32 <0.05STMT-B 110 ± 28.6 107 ± 26 0.3 >0.05
MMSE 30 ± 1.3 30 ± 0.00 0.09 >0.05
showed no signiﬁcant difference could be detected between
group I and group II as regard albumin, calcium and phospho-
rous, on other hand there was signiﬁcant difference as regard
hemoglobin levels. Table 3 showed that transplantation group
had better cognitive performance than ESRD patients. Group
II had a higher values of d-span, while TMT-A  & B were higher
among group I with highly statistically signiﬁcant difference
in between by using unpaired t-test. Table 4 showed that ESRD
patients had cognitive impairment when compared to control
group, but in Table 5 we can see that transplantation group
perform as normal as control group as no statistically sig-
niﬁcant difference could be detected between both groups as
regard psychometric measures by using unpaired t-test. Also
Fig. 2 showed that transplantation group had equal cognitive
performance to control group. And both had better cogni-
tive function when compared to ESRD patients. In Table 6
we  can see that in group I there was no statistically signiﬁ-
cant correlation between psychometric measures versus age,
duration, and URR, on the other hand there was signiﬁcant
correlation between psychometric measures and hemoglobin
levels. As regards transplantation group there was signiﬁcantTMT-B 0.11 >0.05NS −0.12 >0.05NS 0.39 <0.05S
MMSE 0.19 >0.05NS 0.36 <0.05S 0.33 <0.05S
positive correlation between duration versus MMSE and
between hemoglobin levels versus psychometric measures
by using correlation co-efﬁcient test. On the other hand, no
statistically signiﬁcant correlation was found between other
psychometric measures versus age and duration as shown
in Table 7. In group II, no signiﬁcant correlation was found
between cyclosporine level and psychometric measures.
Discussion
Cognitive declines are seen in end-stage renal disease (ESRD)
in patients on chronic hemodialysis. Several studies have
shown elevated risk of dementia in patients with ESRD. How-
ever, modest cognitive declines appear to begin prior to the
point where mild or modest kidney disease has progressed
to ESRD. There is evidence that the rate of cognitive decline
is associated with deterioration in kidney function.9 Kidney
transplantation (TX) is considered to be the preferred treat-
ment for end-stage renal disease (ESRD). Studies on outcomes
after TX have traditionally measured post-operative survival
and complication rates. One area that has received less atten-
tion is the impact of dialysis and TX on neuropsychological
(NP) functioning. This area deserves attention as cognitive
capacity is intimately connected to outcomes such as activ-
ities of daily living and social and vocational adjustments,
n e f r o l o g i a 2 0 1 5;3  5
Table 8 – Correlation between cyclosporine level and
psychometric tests among group II.
Variables Cyclosporine level
r P
D-span 0.15 >0.05
TMT-A 0.26 >0.05
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1TMT-B 0.02 >0.05
MMSE 0.15 >0.05
nd has also been found to be an independent predictor of
ortality.5 Our study focused on evaluating cognitive func-
ions in ESRD on regular hemodialysis with URR > 60% and
ransplantation patients, who were followed till their renal
unctions stabilized. There were marked cognitive impair-
ent among ESRD patients on regular HD when compared to
ontrol group as shown in Table 4 (P < 0.01). This was in agree-
ent with other studies.10,11 There were highly signiﬁcant
ifferences between hemodialysis patients and transplanta-
ion groups as regards mean values of cognitive function tests
core as shown in Table 3 (P < 0.01). Other study5 emphasized
ur ﬁnding and demonstrated improvements in cognition fol-
owing kidney transplantation also it showed that there was
o signiﬁcant cognitive impairment in transplantation group
s compared with control group (P > 0.05), which emphasized
ur ﬁnding as shown in Table 5. Also, in our study there
as signiﬁcant correlation between hemoglobin level and
ognitive function tests in HD patients as shown in Table 6
P < 0.05) and this was in agreement with the studies of other
nvestigators.7,12 Finally, In our study, there were no signiﬁcant
orrelation between cyclosporine trough level and psychomet-
ic tests among transplantation patients as shown in Table 8.
imitations of our study included: (1) Not all possible param-
ters were included such as dietary habits, atherosclerosis,
enetic factors, peritoneal dialysis, different age and eth-
ic groups, medications and immunosuppression drugs and
heir use for longer durations. Further investigations includ-
ng important different confounders are required. (2) This was
 cross-sectional study; thus, associations between hemodial-
sis and cognitive impairment suggest, but do not provide
vidence for a causal relation. It is necessary to conduct a
ongitudinal study for longer durations to clarify the reason
or impaired cognition in hemodialysis patients proving that
emodialysis is a sure independent risk factor for cognitive
mpairment. In conclusion, in our study we found marked
ognitive impairment in HD population when compared to
oth transplantation and control groups. This high preva-
ence of cognitive impairment among hemodialysis patients
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has adverse implications for hospitalization and reduced life
expectancy. Therefore, cognitive impairment in hemodialysis
patients should be routinely monitored carefully and treated
in an appropriate manner. Renal transplantation as a modal-
ity of treatment, in ESRD patients, is superior to hemodialysis
in terms of improving cognitive performance.
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